Zealand Pharma — Director's Dealing 2021

May 3, 2021

FINANSTILSYNET

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Bernadette Connaughton
2.	Reason for the notification
a)	Position/status	Member of the Board of Directors of Zealand Pharma A/S
b)	Initial notification/Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI¹	549300ITBB1ULBL4CZ12
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument
Identification code	Restricted Share Units
DK0060257814
b)	Nature of the transaction	Allocation of Restricted Share Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 205,00	4.000
d)	Aggregated information
- Aggregated volume
- Price	DKK 820.000
e)	Date of the transaction	29 April 2021
f)	Place of the transaction	Outside trading venue